Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program
Pictured: Michael J. Mauro

I am a board-certified hematologist and leader of the Myeloproliferative Neoplasms Program, Leukemia Service at Memorial Sloan Kettering Cancer Center.

My clinical expertise is in treating patients with chronic myeloid leukemia (CML) as well as other myeloproliferative disorders, including myelofibrosis, polycythemia and thrombocytosis as well as less common conditions such as eosinophillic and mast cell disorders. My patient care philosophy is to offer in-depth explanation regarding diagnoses and to engage in active partnership with my patients and their referring providers to personalize decision-making and monitoring given the chronic nature of the disorders I treat.

Before joining Memorial Sloan Kettering, I was on the faculty of Oregon Health and Sciences University for 13 years. There I directed the CML clinical trial program and was involved in the early development and sentinel clinical study of targeted therapy for CML from imatinib (Gleevec) onwards. I completed both residency and fellowship training at the NewYork-Presbyterian Hospital / Weill Cornell Medical College in Manhattan.

Appointments for New Patients
Clinical Expertise

Chronic Myeloid Leukemia; Myelofibrosis; Polycythemia; Thrombocytosis, Other Myeloproliferative Disorders

Languages Spoken

MD, Dartmouth Medical School


NewYork-Presbyterian Hospital/Weill Cornell Medical Center


NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Board Certifications

Internal Medicine; Hematology

Publications by Michael J. Mauro
Visit PubMed for full listing of Michael J. Mauro journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.